Enveric Biosciences (ENVB) Shares Outstanding (2010 - 2026)
Enveric Biosciences (ENVB) recorded Shares Outstanding of 3.99 million in Q2 2026, compared with 216,302 a year earlier and up 164.0% from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) Shares Outstanding (2010 - 2026) Analysis & Trends
For FY2025, Enveric Biosciences reported Shares Outstanding of 334,719, up 698.7% from FY2024.
- Annual Shares Outstanding has increased for three straight years, with a five-year compound annual growth rate of 60.0% (FY2020 to FY2025).
- Across earlier years, Shares Outstanding came in at 41,907 in FY2024 (+249.4%), 11,995 in FY2023 (+49.3%), 8,033 in FY2022 (-93.9%) and 131,207 in FY2021 (+310.5%).
- The Q2 2026 figure is the highest quarterly Shares Outstanding in data going back to Q3 2010.
- Peak year-over-year performance for Shares Outstanding in the last five years was growth of 908.2% in Q1 2026, against a decline of 95.1% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 1.51 million (Q1 2026), 334,719 (Q4 2025) and 313,242 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Enveric Biosciences | 5.86 Mn | -15.78 Mn | - | 3.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.99 Mn |
| Mar 31, 2026 | 1.51 Mn |
| Dec 31, 2025 | 334,719.00 |
| Sep 30, 2025 | 313,242.00 |
| Jun 30, 2025 | 216,302.00 |
| Mar 31, 2025 | 149,809.00 |
| Dec 31, 2024 | 41,907.00 |
| Sep 30, 2024 | 48,350.00 |
| Jun 30, 2024 | 42,155.00 |
| Mar 31, 2024 | 22,231.00 |
| Dec 31, 2023 | 11,995.00 |
| Sep 30, 2023 | 12,026.00 |
| Jun 30, 2023 | 11,709.00 |
| Mar 31, 2023 | 11,546.00 |
| Dec 31, 2022 | 8,033.00 |
| Sep 30, 2022 | 9,929.00 |
| Jun 30, 2022 | 5,854.00 |
| Mar 31, 2022 | 235,318.00 |
| Dec 31, 2021 | 131,207.00 |
| Sep 30, 2021 | 128,572.00 |
API Access
Enveric Biosciences Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();